The Trump administration has ordered the termination of federal Medicaid and CHIP funding for puberty blockers, cross-sex hormones, and surgeries on minors, effective October 13, following an HHS review citing evidence gaps. Existing recipients may receive up to six months of tapering support, while mental-health coverage continues and states retain authority to use their own funds. The policy draws from statements in RT and Breitbart, with several details remaining unverified.